Tadayasu Togawa

2.8k total citations · 1 hit paper
72 papers, 2.3k citations indexed

About

Tadayasu Togawa is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Tadayasu Togawa has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Physiology, 23 papers in Epidemiology and 20 papers in Organic Chemistry. Recurrent topics in Tadayasu Togawa's work include Lysosomal Storage Disorders Research (45 papers), Trypanosoma species research and implications (23 papers) and Carbohydrate Chemistry and Synthesis (18 papers). Tadayasu Togawa is often cited by papers focused on Lysosomal Storage Disorders Research (45 papers), Trypanosoma species research and implications (23 papers) and Carbohydrate Chemistry and Synthesis (18 papers). Tadayasu Togawa collaborates with scholars based in Japan, United States and China. Tadayasu Togawa's co-authors include Yuki Ogasawara, Kazuyuki Ishii, Norihiro Shibuya, Mikiharu Yoshida, Hideo Kimura, M. Tanaka, Hitoshi Sakuraba, Takahiro Tsukimura, Toshihiro Suzuki and Shinzo Tanabe and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Tadayasu Togawa

70 papers receiving 2.3k citations

Hit Papers

3-Mercaptopyruvate Sulfurtransferase Produces Hydrogen Su... 2008 2026 2014 2020 2008 250 500 750

Peers

Tadayasu Togawa
John E. Dominy United States
Juan I. Sbodio United States
Xinggui Shen United States
Lei Ding China
Philippa B. Mills United Kingdom
Stephen Marshall United States
S.K. Wadman Netherlands
John E. Dominy United States
Tadayasu Togawa
Citations per year, relative to Tadayasu Togawa Tadayasu Togawa (= 1×) peers John E. Dominy

Countries citing papers authored by Tadayasu Togawa

Since Specialization
Citations

This map shows the geographic impact of Tadayasu Togawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadayasu Togawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadayasu Togawa more than expected).

Fields of papers citing papers by Tadayasu Togawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadayasu Togawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadayasu Togawa. The network helps show where Tadayasu Togawa may publish in the future.

Co-authorship network of co-authors of Tadayasu Togawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tadayasu Togawa. A scholar is included among the top collaborators of Tadayasu Togawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadayasu Togawa. Tadayasu Togawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukimura, Takahiro, et al.. (2024). Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?. Molecular Genetics and Metabolism Reports. 39. 101079–101079. 1 indexed citations
3.
Tsukimura, Takahiro, et al.. (2020). Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor. Molecular Genetics and Metabolism Reports. 25. 100639–100639. 6 indexed citations
5.
Tsukimura, Takahiro, et al.. (2020). Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy. Molecular Genetics and Metabolism Reports. 25. 100650–100650. 8 indexed citations
6.
Sakuraba, Hitoshi, Takahiro Tsukimura, Tadayasu Togawa, et al.. (2018). Fabry disease in a Japanese population-molecular and biochemical characteristics. Molecular Genetics and Metabolism Reports. 17. 73–79. 27 indexed citations
7.
Kodama, Takashi, Takahiro Tsukimura, Ikuo Kawashima, et al.. (2016). Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy. Molecular Genetics and Metabolism. 120(1-2). 116–120. 9 indexed citations
8.
Kubo, Toru, Yuichi Baba, Takayoshi Hirota, et al.. (2016). Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. Journal of Cardiology. 69(1). 302–307. 27 indexed citations
9.
Tsukimura, Takahiro, Tadayasu Togawa, Toya Ohashi, et al.. (2015). Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy. PLoS ONE. 10(6). e0128351–e0128351. 12 indexed citations
10.
Nishida, Masashi, Koh Hasegawa, Toshiyuki Itoi, et al.. (2013). A case of Fabry nephropathy with histological features of oligonephropathy. European Journal of Pediatrics. 173(8). 1111–1114. 6 indexed citations
11.
Togawa, Tadayasu, Takahiro Tsukimura, Takashi Kodama, et al.. (2012). Fabry disease: Biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution. Molecular Genetics and Metabolism. 105(4). 615–620. 33 indexed citations
12.
Togawa, Tadayasu, Ikuo Kawashima, Takashi Kodama, et al.. (2010). Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease. Biochemical and Biophysical Research Communications. 399(4). 716–720. 31 indexed citations
13.
Togawa, Tadayasu, Takashi Kodama, Toshihiro Suzuki, et al.. (2010). Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Molecular Genetics and Metabolism. 100(3). 257–261. 118 indexed citations
14.
Tajima, Youichi, Ikuo Kawashima, Takahiro Tsukimura, et al.. (2009). Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease. The American Journal of Human Genetics. 85(5). 569–580. 41 indexed citations
15.
Shibuya, Norihiro, M. Tanaka, Mikiharu Yoshida, et al.. (2008). 3-Mercaptopyruvate Sulfurtransferase Produces Hydrogen Sulfide and Bound Sulfane Sulfur in the Brain. Antioxidants and Redox Signaling. 11(4). 703–714. 803 indexed citations breakdown →
16.
Tajima, Youichi, Fumiko Matsuzawa, Kunihiko Iwamoto, et al.. (2008). Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid α-glucosidase (alglucosidase alfa): Insight into the complex formation mechanism. Clinica Chimica Acta. 391(1-2). 68–73. 35 indexed citations
17.
Saito, Seiji, Kazuki Ohno, Kanako Sugawara, et al.. (2008). Structural basis of aspartylglucosaminuria. Biochemical and Biophysical Research Communications. 377(4). 1168–1172. 11 indexed citations
18.
Ogasawara, Yuki, et al.. (2005). Formation of albumin dimers induced by exposure to peroxides in human plasma: A possible biomarker for oxidative stress. Biochemical and Biophysical Research Communications. 340(2). 353–358. 46 indexed citations
19.
Yoshikawa, Megumi, Yoji Ikegami, Kazuyuki Ishii, et al.. (2004). Novel camptothecin analogues that circumvent ABCG2‐associated drug resistance in human tumor cells. International Journal of Cancer. 110(6). 921–927. 45 indexed citations
20.
Togawa, Tadayasu, et al.. (2002). Determination of homocysteine thiolactone and homocysteine in cell cultures using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B. 767(2). 263–268. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026